Replies to post #234752 on Biotech Values

[vinmantoo]

Haven't sold a share and have bought any more tranches as the price has increased. My last outright purchase was in the $5 range and have exercised some calls along the way.

Thanks. I have plenty of cash on hand so no need to sell, just wondering.

As far as your faux pas with shares of TRIL, a few months ago I went to increase my shares of EXEL by 10%. I entered the buy order but somehow entered the wrong share number so increased by 40%. Then about two weeks ago I went to reduced my shares by 10% but mistakenly hit buy instead of sell. I toyed with the idea of just keeping the shares but decided later in the day to do what I set out to do so sold the new shares along with the original amount I mean to sell. Of course the EXEL jumped $5 in the week after I sold, although it gave about half that back this week. No crying as I have the extra cash ready.

[seschm]

you mentioned earlier that you planned to take some gains after they were long term in the December timeframe if I remember correctly. I own 1/2 your shares (although at an average price of about $3) and at this point.. i have to see some solid tumor data before I sell anything. You still thinking about selling given the great monotherapy numbers?

take care

Paul